BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025

  May 12, 2025

   · 

  2 min read
• Press Releases

  Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

  May 12, 2025

   · 

  6 min read
• Press Releases

  Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis

  May 12, 2025

   · 

  12 min read
• Press Releases

  Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025

  May 12, 2025

   · 

  2 min read
• Press Releases

  Faron Pharmaceuticals Presents Promising Phase 1/2 Data from BEXMAB Study at MDS 2025 Plenary Session

  May 12, 2025

   · 

  7 min read
• Press Releases

  Redwire Corporation Reports First Quarter 2025 Financial Results

  May 12, 2025

   · 

  19 min read
• Press Releases

  Rockwell Medical Announces First Quarter 2025 Results

  May 12, 2025

   · 

  10 min read
• Press Releases

  Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

  May 12, 2025

   · 

  11 min read
• Press Releases

  Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025

  May 12, 2025

   · 

  2 min read
• Press Releases

  TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025

  May 12, 2025

   · 

  2 min read